META Pharmaceuticals Inc.
PrivateLast Round
Series A
Extension
Dec 1, 2024
Total Funding Raised
$21.1M
Company Overview
META Pharmaceuticals Inc. operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Series A Extension round in December 2024.
META Pharmaceuticals Inc. is a biopharmaceutical company that develops first-in-class small molecule drugs targeting immunometabolism for the treatment of autoimmune and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
META Pharmaceuticals Inc. Comparables
Compare META Pharmaceuticals Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sitryx | 82% | |
| NImmune Biopharma | 78% | |
| Inapill | 77% |
For institutional investors. Book with your work email.
META Pharmaceuticals Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 1, 2024 | ||||
| Series A | Mar 1, 2022 | ||||
| Seed | Sep 1, 2021 |
For institutional investors. Book with your work email.
META Pharmaceuticals Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tiantu Capital | Series A, Seed |
| IMO Ventures | Series A Extension, Series A, Seed |
META Pharmaceuticals Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about META Pharmaceuticals Inc.'s valuation, stock price, and market status.
Is META Pharmaceuticals Inc. a public or private company?
META Pharmaceuticals Inc. is a private company.
What is the current stock price of META Pharmaceuticals Inc.?
META Pharmaceuticals Inc. is a private company, so its shares have no public market price. Caplight tracks META Pharmaceuticals Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is META Pharmaceuticals Inc. worth (valuation)?
Valuation information for META Pharmaceuticals Inc. is not publicly available.
Can I buy META Pharmaceuticals Inc. stock?
META Pharmaceuticals Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was META Pharmaceuticals Inc.'s last funding round?
META Pharmaceuticals Inc.'s most recent funding round was Series A Extension on December 1, 2024.
Who are the main investors in META Pharmaceuticals Inc.?
Key investors in META Pharmaceuticals Inc. include Tiantu Capital, IMO Ventures.
Will META Pharmaceuticals Inc. IPO soon?
No public IPO plans have been announced for META Pharmaceuticals Inc..
How can I track META Pharmaceuticals Inc. secondary market activity?
Caplight tracks bids, offers, and trades in META Pharmaceuticals Inc.'s shares on secondary markets.